2 Feb 2021 | Primary Care
The Tongan Health Society is working on an innovative approach to underpin best practice models for patients with diabetes who are on maximum oral hypoglycaemic medication to start insulin therapy when they are hesitant to do so.
Dr Glenn Doherty, CEO and Medical Director for the Tongan Health Society Inc. initially developed the project and related research with assistance from the Ministry of Health Pacific Innovation Fund which ran concurrently with the Whakakotahi initiative.
You can read the case study here. This project is supported by PHARMAC Te Pātaka Whaioranga.